Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens.

Ly D, Kasmar AG, Cheng TY, de Jong A, Huang S, Roy S, Bhatt A, van Summeren RP, Altman JD, Jacobs WR Jr, Adams EJ, Minnaard AJ, Porcelli SA, Moody DB.

J Exp Med. 2013 Apr 8;210(4):729-41. doi: 10.1084/jem.20120624. Epub 2013 Mar 25.

2.

Molecular basis of mycobacterial lipid antigen presentation by CD1c and its recognition by αβ T cells.

Roy S, Ly D, Li NS, Altman JD, Piccirilli JA, Moody DB, Adams EJ.

Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):E4648-57. doi: 10.1073/pnas.1408549111. Epub 2014 Oct 8.

3.

Mycoketide: a CD1c-presented antigen with important implications in mycobacterial infection.

Matsunaga I, Sugita M.

Clin Dev Immunol. 2012;2012:981821. doi: 10.1155/2012/981821. Epub 2012 Mar 26. Review.

4.

Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells.

Matsunaga I, Bhatt A, Young DC, Cheng TY, Eyles SJ, Besra GS, Briken V, Porcelli SA, Costello CE, Jacobs WR Jr, Moody DB.

J Exp Med. 2004 Dec 20;200(12):1559-69.

5.

Diverse antigen presentation by the Group 1 CD1 molecule, CD1c.

Adams EJ.

Mol Immunol. 2013 Sep;55(2):182-5. doi: 10.1016/j.molimm.2012.10.019. Epub 2012 Nov 3. Review.

6.

Molecular Analysis of Lipid-Reactive Vδ1 γδ T Cells Identified by CD1c Tetramers.

Roy S, Ly D, Castro CD, Li NS, Hawk AJ, Altman JD, Meredith SC, Piccirilli JA, Moody DB, Adams EJ.

J Immunol. 2016 Feb 15;196(4):1933-42. doi: 10.4049/jimmunol.1502202. Epub 2016 Jan 11.

PMID:
26755823
7.

CD1 and mycobacterial lipids activate human T cells.

Van Rhijn I, Moody DB.

Immunol Rev. 2015 Mar;264(1):138-53. doi: 10.1111/imr.12253. Review.

8.

CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family.

Beckman EM, Melián A, Behar SM, Sieling PA, Chatterjee D, Furlong ST, Matsumoto R, Rosat JP, Modlin RL, Porcelli SA.

J Immunol. 1996 Oct 1;157(7):2795-803.

PMID:
8816382
9.

CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection.

Moody DB, Ulrichs T, Mühlecker W, Young DC, Gurcha SS, Grant E, Rosat JP, Brenner MB, Costello CE, Besra GS, Porcelli SA.

Nature. 2000 Apr 20;404(6780):884-8.

PMID:
10786796
10.

CD1b tetramers bind αβ T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans.

Kasmar AG, van Rhijn I, Cheng TY, Turner M, Seshadri C, Schiefner A, Kalathur RC, Annand JW, de Jong A, Shires J, Leon L, Brenner M, Wilson IA, Altman JD, Moody DB.

J Exp Med. 2011 Aug 29;208(9):1741-7. doi: 10.1084/jem.20110665. Epub 2011 Aug 1.

11.

Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation.

Kawasaki N, Rillahan CD, Cheng TY, Van Rhijn I, Macauley MS, Moody DB, Paulson JC.

J Immunol. 2014 Aug 15;193(4):1560-6. doi: 10.4049/jimmunol.1303278. Epub 2014 Jul 7.

12.

T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection.

Ulrichs T, Moody DB, Grant E, Kaufmann SH, Porcelli SA.

Infect Immun. 2003 Jun;71(6):3076-87.

13.

Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens.

Hiromatsu K, Dascher CC, LeClair KP, Sugita M, Furlong ST, Brenner MB, Porcelli SA.

J Immunol. 2002 Jul 1;169(1):330-9.

14.

Deciphering the role of CD1e protein in mycobacterial phosphatidyl-myo-inositol mannosides (PIM) processing for presentation by CD1b to T lymphocytes.

Cala-De Paepe D, Layre E, Giacometti G, Garcia-Alles LF, Mori L, Hanau D, de Libero G, de la Salle H, Puzo G, Gilleron M.

J Biol Chem. 2012 Sep 7;287(37):31494-502. doi: 10.1074/jbc.M112.386300. Epub 2012 Jul 10.

15.

CD1c molecules broadly survey the endocytic system.

Sugita M, van Der Wel N, Rogers RA, Peters PJ, Brenner MB.

Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8445-50.

16.

Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes.

Aquino A, Graziani G, Franzese O, Prete SP, Bonmassar E, Bonmassar L, D'Atri S.

Clin Dev Immunol. 2011;2011:790460. doi: 10.1155/2011/790460. Epub 2011 Mar 22. Review.

17.

The 2.5 Å structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation.

Scharf L, Li NS, Hawk AJ, Garzón D, Zhang T, Fox LM, Kazen AR, Shah S, Haddadian EJ, Gumperz JE, Saghatelian A, Faraldo-Gómez JD, Meredith SC, Piccirilli JA, Adams EJ.

Immunity. 2010 Dec 14;33(6):853-62. doi: 10.1016/j.immuni.2010.11.026.

18.

A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.

Lepore M, de Lalla C, Gundimeda SR, Gsellinger H, Consonni M, Garavaglia C, Sansano S, Piccolo F, Scelfo A, Häussinger D, Montagna D, Locatelli F, Bonini C, Bondanza A, Forcina A, Li Z, Ni G, Ciceri F, Jenö P, Xia C, Mori L, Dellabona P, Casorati G, De Libero G.

J Exp Med. 2014 Jun 30;211(7):1363-77. doi: 10.1084/jem.20140410. Epub 2014 Jun 16.

19.

Presentation of the same glycolipid by different CD1 molecules.

Shamshiev A, Gober HJ, Donda A, Mazorra Z, Mori L, De Libero G.

J Exp Med. 2002 Apr 15;195(8):1013-21.

20.

CD1a, CD1b, and CD1c in immunity against mycobacteria.

Van Rhijn I, Ly D, Moody DB.

Adv Exp Med Biol. 2013;783:181-97. doi: 10.1007/978-1-4614-6111-1_10. Review.

PMID:
23468110
Items per page

Supplemental Content

Write to the Help Desk